AAAAAA

   
Results: 1-8 |
Results: 8
Adult height and age at menarche in childhood cancer survivors
Authors: Noorda, EM Somers, R van Leeuwen, FE Vulsma, T Behrendt, H
Citation: Em. Noorda et al., Adult height and age at menarche in childhood cancer survivors, EUR J CANC, 37(5), 2001, pp. 605-612
Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: Comparison with cathepsin D, cathepsin L, and other clinical indicators
Authors: Lah, TT Cercek, M Blejec, A Kos, J Gorodetsky, E Somers, R Daskal, I
Citation: Tt. Lah et al., Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: Comparison with cathepsin D, cathepsin L, and other clinical indicators, CLIN CANC R, 6(2), 2000, pp. 578-584
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
Authors: van Leeuwen, FE Klokman, WJ van't Veer, MB Hagenbeek, A Krol, ADG Vetter, UAO Schaapveld, M van Heerde, P Burgers, JMV Somers, R Aleman, BMP
Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497
Cells producing cathepsins D, B, and L in human breast carcinoma and theirassociation with prognosis
Authors: Lah, TT Kalman, E Najjar, D Gorodetsky, E Brennan, P Somers, R Daskal, I
Citation: Tt. Lah et al., Cells producing cathepsins D, B, and L in human breast carcinoma and theirassociation with prognosis, HUMAN PATH, 31(2), 2000, pp. 149-160
The EORTC phase II study of iproplatin in advanced osteogenic sarcoma
Authors: Pawinski, A Crowther, D Keizer, HJ Voute, PA Somers, R van Glabbeke, M Lentz, MA van Oosterom, AT
Citation: A. Pawinski et al., The EORTC phase II study of iproplatin in advanced osteogenic sarcoma, EUR J CANC, 35(1), 1999, pp. 163-164
A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma
Authors: Voute, PA Souhami, RL Nooij, M Somers, R Cortes-Funes, H van der Eijken, JW Pringle, J Hogendoorn, PCW Kirkpatrick, A Uscinska, BM van Glabbeke, M Machin, D Weeden, S
Citation: Pa. Voute et al., A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma, ANN ONCOL, 10(10), 1999, pp. 1211-1218
Prognostic factors for the outcome of chemotherapy in advanced soft tissuesarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatmentof Cancer Soft Tissue and Bone Sarcoma Group Study
Authors: Van Glabbeke, M van Oosterom, AT Oosterhuis, JW Mouridsen, H Crowther, D Somers, R Verweij, J Santoro, A Buesa, J Tursz, T
Citation: M. Van Glabbeke et al., Prognostic factors for the outcome of chemotherapy in advanced soft tissuesarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatmentof Cancer Soft Tissue and Bone Sarcoma Group Study, J CL ONCOL, 17(1), 1999, pp. 150-157
Contributions of the international database on Hodgkin's disease
Authors: Loeffler, M Henry-Amar, M Somers, R
Citation: M. Loeffler et al., Contributions of the international database on Hodgkin's disease, HODGKIN'S DISEASE, 1999, pp. 741-751
Risultati: 1-8 |